The differential expression of SLC7A6 in CD8 + T cells, treatment naive BCa cells and cisplatin resistant BCa cells suggest that cisplatin resistance cancer cells may outcompete T cells for the consumption of methionine via SLC7A6 to overcome cisplatin resistance. This evidence concerns the gene SLC7A6 and cancer.